ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Jun 22, 2023 Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2023 Financial Results on June 30, 2023

May 03, 2023 Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officer

Apr 20, 2023 Elite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite Product

Feb 14, 2023 Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information

Feb 08, 2023 Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2023 Financial Results on February 15, 2023

Feb 07, 2023 Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study

Dec 22, 2022 Elite Pharmaceuticals Files ANDA with US FDA to Market Dopamine Agonist

Nov 15, 2022 Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023 Ended September 30, 2022 and Provides Conference Call Information

Nov 08, 2022 Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2023 Financial Results on November 15, 2022

Nov 02, 2022 Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study

1 2 3 4 5 6 7 8

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.

Resize Viewer - Reduce

Resize Viewer - Expand